Bidmos, F., Nadel, S., Screaton, G., Kroll, J., & Langford, P. (2018). Cross-reactive bactericidal antimeningococcal antibodies can be isolated from convalescing invasive meningococcal disease patients using reverse vaccinology 2.0. Frontiers Research Foundation.
Citace podle Chicago (17th ed.)Bidmos, F., S. Nadel, G. Screaton, J. Kroll, a P. Langford. Cross-reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated from Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0. Frontiers Research Foundation, 2018.
Citace podle MLA (9th ed.)Bidmos, F., et al. Cross-reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated from Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0. Frontiers Research Foundation, 2018.